Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus–uninfected Individuals in HPTN 077
Raphael J. Landovitz(APLA Health), Judith S. Currier(University of California, Los Angeles), Myron S. Cohen(University of North Carolina at Chapel Hill), Joseph J. Eron(University of North Carolina at Chapel Hill), Halima Dawood(Centre for the AIDS Programme of Research in South Africa), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Marybeth McCauley(Family Health International 360), Ravindre Panchia(Chris Hani Baragwanath Hospital), Albert Liu(San Francisco Department of Public Health), Manya Magnus(Milken Institute), Ryan Kofron(APLA Health), Sahar Z. Zangeneh(Fred Hutch Cancer Center), Alex R. Rinehart, David Burns(Norwegian Womens Public Health Association), David A. Margolis(Medical College of Wisconsin), Mina C. Hosseinipour, Gordon Chau(Fred Hutch Cancer Center), Adeola Adeyeye(National Institutes of Health)
Cited by 45
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k